Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy

NCT07600177 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT07600177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07600177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Lead sponsor
Oregon Health and Science University
Phase
Phase 4
Overall status
Recruiting
Start date
May 5, 2026
Completion date
March 15, 2027
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy (hcm)